Alveolar macrophages are the main source for tumour necrosis factor-α in patients with sarcoidosis Source: Eur Respir J 2003; 21: 421-428 Year: 2003
Effects of zinc on the interleukin-1 and tumor necrosis factor in experimental silicosis Source: Eur Respir J 2002; 20: Suppl. 38, 517s Year: 2002
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement Source: Eur Respir J 2010; 36: 1185-1206 Year: 2010
Levels of plasma tumour necrosis factor and soluble tumour necrosis factor receptor in patients with COPD and its relation to glucocorticoid receptor levels Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009
Tumor necrosis factor alpha inhibitors and reactivation of tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 281s Year: 2007
Role of tumor necrosis factor alpha in hepatopulmonary syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 562s Year: 2004
The levels of tumour necrosis factor-alpha and interleukin-1 in newly diagnosed and multi drug resistant tuberculosis Source: Annual Congress 2004 - Clinical and diagnostic features of tuberculosis Year: 2004
Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma in lung cancer complicated with metastatic pleurisy Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001
Tumour necrosis factor and lymphotoxin A polymorphisms: a relationship with COPD and its progression? Source: Eur Respir J 2007; 29: 8-10 Year: 2007
Increased expression of tumor necrosis factor receptors by bronchoalveolar cells in cryptogenic organising pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 565s Year: 2006
Tumor necrosis factor-α gene polymorphism and inflammatory process in cystic fibrosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 403s Year: 2005
Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interleukin (IL) 1-beta in small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001
Tuberculosis and tumor necrosis factor alpha antagonist: Our experience Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012
Mycobacterial diseases developed during anti-tumour necrosis factor alpha therapy Source: Eur Respir J 2014; 44: 1289-1295 Year: 2014
HLA-DP-unrestricted TNF-α release in beryllium-stimulated peripheral blood mononuclear cells Source: Eur Respir J 2002; 20: 1174-1178 Year: 2002
Tumour necrosis factor gene polymorphisms and childhood wheezing Source: Eur Respir J 2005; 26: 637-646 Year: 2005
Mast cell-derived tumour necrosis factor is essential for allergic airway disease Source: Eur Respir J 2008; 31: 773-782 Year: 2008
Implication of leptin, tumor necrosis factor-alpha, interleukin-1 and interleukin-6 in the pathogenesis of wasting in tuberculosis Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection Year: 2006
Does tumour necrosis factor-alpha (TNF-alpha) induced by lipopolysaccharide have a positive feedback effect on the up-regulation of interleukin-8 (IL-8) messenger RNA by monocytes from COPD patients? Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013
The haplotypes of interleukin 10 but not that of tumour necrosis factor alpha/lymphotoxin alpha and interleukin 1 cluster are associated with susceptibility for COPD Source: Eur Respir J 2005; 26: Suppl. 49, 105s Year: 2005